New Medications for Substance Use Disorders: Challenges and Opportunities

被引：46
|
作者：
Volkow, Nora D. [1 ]
Skolnick, Phil [1 ]
机构：
[1] NIDA, Bethesda, MD 20892 USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2012年 / 37卷 / 01期
关键词：
ABUSE;
D O I：
10.1038/npp.2011.84
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
An increased understanding of the biological mechanisms underlying the process of addiction has led to unique molecular targets and strategies for pharmacotherapies against addiction. However, the successful translation of these discoveries will require: 1) a more active engagement of the pharmaceutical sector, 2) partnership with regulatory agencies to arrive at meaningful outcomes for medication approval and 3) a greater involvement of the healthcare system in the screening and treatment of substance use disorders. Neuropsychopharmacology Reviews (2012) 37, 290-292; doi: 10.1038/npp.2011.84
引用
收藏
页码：290 / 292
页数：3
相关论文
共 50 条
12345